Format

Send to

Choose Destination
MAbs. 2015;7(5):838-52. doi: 10.1080/19420862.2015.1068492.

MoFvAb: Modeling the Fv region of antibodies.

Author information

1
a Roche Pharmaceutical Research and Early Development; Large Molecule Research; Roche Innovation Center Penzberg ; Penzberg , Germany.

Abstract

Knowledge of the 3-dimensional structure of the antigen-binding region of antibodies enables numerous useful applications regarding the design and development of antibody-based drugs. We present a knowledge-based antibody structure prediction methodology that incorporates concepts that have arisen from an applied antibody engineering environment. The protocol exploits the rich and continuously growing supply of experimentally derived antibody structures available to predict CDR loop conformations and the packing of heavy and light chain quickly and without user intervention. The homology models are refined by a novel antibody-specific approach to adapt and rearrange sidechains based on their chemical environment. The method achieves very competitive all-atom root mean square deviation values in the order of 1.5 Å on different evaluation datasets consisting of both known and previously unpublished antibody crystal structures.

KEYWORDS:

AMA, Antibody Modeling Assessment; RMSD, root mean square deviation; amino acid sidechain conformation; antibody structure; homology modeling; macromolecular modeling; protein domain orientation; protein engineering; protein structure prediction

PMID:
26176812
PMCID:
PMC4622929
DOI:
10.1080/19420862.2015.1068492
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Taylor & Francis Icon for PubMed Central
Loading ...
Support Center